RAPT Therapeutics Inc (RAPT)
7.93
+0.23
(+2.99%)
USD |
NASDAQ |
May 01, 10:50
RAPT Therapeutics Total Return Level: 7.70 for April 30, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 30, 2024 | 7.70 |
April 29, 2024 | 7.88 |
April 26, 2024 | 8.10 |
April 25, 2024 | 7.80 |
April 24, 2024 | 7.90 |
April 23, 2024 | 8.00 |
April 22, 2024 | 7.86 |
April 19, 2024 | 7.95 |
April 18, 2024 | 7.93 |
April 17, 2024 | 8.04 |
April 16, 2024 | 8.13 |
April 15, 2024 | 8.54 |
April 12, 2024 | 9.19 |
April 11, 2024 | 9.38 |
April 10, 2024 | 9.02 |
April 09, 2024 | 8.44 |
April 08, 2024 | 8.32 |
April 05, 2024 | 7.90 |
April 04, 2024 | 8.01 |
April 03, 2024 | 8.36 |
April 02, 2024 | 8.21 |
April 01, 2024 | 8.45 |
March 28, 2024 | 8.98 |
March 27, 2024 | 8.93 |
March 26, 2024 | 8.40 |
Date | Value |
---|---|
March 25, 2024 | 8.27 |
March 22, 2024 | 8.33 |
March 21, 2024 | 8.51 |
March 20, 2024 | 8.68 |
March 19, 2024 | 8.64 |
March 18, 2024 | 8.33 |
March 15, 2024 | 8.47 |
March 14, 2024 | 8.41 |
March 13, 2024 | 8.58 |
March 12, 2024 | 7.97 |
March 11, 2024 | 8.10 |
March 08, 2024 | 9.08 |
March 07, 2024 | 9.28 |
March 06, 2024 | 9.14 |
March 05, 2024 | 8.68 |
March 04, 2024 | 8.67 |
March 01, 2024 | 8.98 |
February 29, 2024 | 8.57 |
February 28, 2024 | 8.66 |
February 27, 2024 | 8.99 |
February 26, 2024 | 9.42 |
February 23, 2024 | 8.72 |
February 22, 2024 | 9.24 |
February 21, 2024 | 10.18 |
February 20, 2024 | 6.87 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
6.87
Minimum
Feb 20 2024
48.86
Maximum
Jan 27 2020
22.98
Average
21.75
Median
Nov 12 2019
Total Return Level Benchmarks
Emergent BioSolutions Inc | 1.88 |
Avinger Inc | 3.74 |
Tonix Pharmaceuticals Holding Corp | 0.1784 |
Skye Bioscience Inc | 12.93 |
Axsome Therapeutics Inc | 73.72 |